Stifel Firstegy Equities Analysts Decrease Earnings Estimates for STERIS’ (TSE:STE)

STERIS’ (TSE:STEGet Rating) – Stock analysts at Stifel Firstegy dropped their FY2022 earnings per share (EPS) estimates for shares of STERIS’ in a research note issued on Tuesday, January 17th. Stifel Firstegy analyst C. Pereira now expects that the company will post earnings per share of $1.01 for the year, down from their previous forecast of $1.39. Stifel Firstegy also issued estimates for STERIS’’s FY2023 earnings at $1.58 EPS and FY2024 earnings at $1.80 EPS.

STERIS’ Stock Performance

STERIS’ (TSE:STEGet Rating) last posted its quarterly earnings results on Wednesday, November 2nd. The company reported C$0.43 EPS for the quarter, topping analysts’ consensus estimates of C$0.28 by C$0.15. The business had revenue of C$245.09 million for the quarter, compared to the consensus estimate of C$267.57 million.

About STERIS’

(Get Rating)

STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.

Recommended Stories

Earnings History and Estimates for STERIS’ (TSE:STE)

Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.